News | National Commission on Correctional Health Care
As we work with more facilities seeking to treat patients with opioid use disorder, a specific challenge has emerged with injectable extended-release naltrexone (XR-NTX).
As our approach to COVID-19 takes a new turn with the introduction of vaccines, it’s time to prepare for educating staff and incarcerated people
by James W. Grigg, MD, Ross MacDonald, MD, and Rachael Bedard, MD. A significant amount of national attention has focused on the risks of coronavirus
Centurion Health has made a generous gift to the NCCHC Foundation in support of conference scholarships.
2021 welcome jpg e1609277319526
by Joseph V. Penn, MD, CCHP-MH As we bid farewell to 2020 and welcome 2021, I hope that you are feeling encouraged by the
coronavirus behind bars e1609262088119
Q: I am concerned about maintaining our facility’s accreditation status because, in response to COVID, we have made some changes in the way we
covid virus from webinar 150w
A recent article in the Chicago Tribune pointed out that COVID-19 vaccine rates for prison staffers were alarmingly low.  “In Massachusetts, more than half
The Spring Conference will feature keynotes on Lessons Learned From COVID-19 and Medication-Assisted Treatment – at no charge to attendees.
shutterstock 710888533 saved 150sq
Whitney was six months pregnant and struggling with opioid use disorder (OUD) when she got to jail. But the jail did not provide her
covid virus from webinar 150w
I wanted to pass on some new and highly relevant information on exciting medical innovations highlighted by our colleagues at the HHS/Assistant Secretary for
The NCCHC Foundation is pleased to announce Indivior’s Platinum Level support for the Foundation’s Partners in Correctional Health Annual Giving Society. The global pharmaceutical
pexels engin akyurt 3356489 150sq
For those of us who provide treatment in juvenile correctional settings, the resilience demonstrated by our adolescent patients constantly reminds of us why we